Evofem Biosciences, Inc.
EVFM
$0.01
$0.0016.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.66% | -232.05% | 119.88% | -43.66% | -103.58% |
| Total Depreciation and Amortization | -59.86% | 221.43% | 350.85% | 1,368.18% | 694.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -47.09% | 119.29% | -376.10% | 217.65% | 101.45% |
| Change in Net Operating Assets | 100.95% | -43,850.00% | 95.25% | -157.74% | 201.94% |
| Cash from Operations | 173.20% | -155.83% | 355.28% | -1,316.47% | 80.58% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -307.14% | -- | -- |
| Total Debt Issued | -- | 607.30% | -- | -100.00% | -100.00% |
| Total Debt Repaid | 6.87% | 1.98% | -- | -73.38% | 73.80% |
| Issuance of Common Stock | -- | -- | -- | 4,210.34% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -124.45% | 123.78% | -- | 627.35% | -53.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 206.67% | -12,133.33% | 237.61% | -88.82% | 113.27% |